US Patent
US9132239 — Dial-down mechanism for wind-up pen
Formulation · Assigned to Novo Nordisk AS · Expires 2032-02-01 · 6y remaining
Vulnerability score
39/100
Strong — defensible against typical IPR challenges
What this patent protects
This patent protects a dial-down mechanism for an injection device that assists in injecting a dose of medicament.
USPTO Abstract
The present invention relates to a dial-down mechanism for an injection device comprising a torsion spring for assisting injection of a dose of medicament from the injection device, the dial-down mechanism comprising a ratchet arm ( 21 ) engaging a ring element ( 10 ) and a reset element ( 30 ) which acts on a knob located on the periphery of the ratchet arm ( 21 ) to move the ratchet arm ( 21 ) out of engagement with the ring element ( 10 ) in order to allow the set dose to be reduced.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.